Investing Profile
Gary Patou
VC
Managing Director at MPM Capital
Your Intro Paths to Gary Patou
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Gary is a member of
GSK Network
32 CONNECTIONS
GSK Network
32 CONNECTIONS
MPM BioImpact Network
20 CONNECTIONS
MPM BioImpact Network
20 CONNECTIONS
University College London, U. of London Network
13 CONNECTIONS
Find Gary Patou on
cbCurrent Investing Position
MPM Capital Managing Director
Current Fund Size
$100M
Gary Patou is on these Sector & Stage Rankings
Gary Patou's Experience
Managing Director MPM Capital2005 - Present
Vice President, Anti-infectives GSKPresent
Senior Vice President, Drug Development Projects GSKPresent
President and Chief Medical Officer PrimeraPresent
Board Member Xenon Pharmaceuticals Inc.Present
Managing Director MPM BioImpactPresent
Chief Medical Officer PeplinPresent
Chief Medical Officer Pacira BioSciences, Inc.Present
Head of Clinical ChiasmaPresent
Chief Medical Officer True North TherapeuticsPresent
Senior Clinical Consultant Bioverativ, a Sanofi companyPresent
Chief Medical Officer PrimeraPresent
Chief Medical Officer Blade TherapeuticsPresent
Advisor MPM BioImpactPresent
Clinical Advisor Electra TherapeuticsPresent
Chief Medical Officer Pacira Pharmaceuticals, Inc.2009 - 2015
Chief Medical Officer Peplin Ltd2006 - 2008
President and Chief Medical Officer Genesoft Pharmaceuticals2001 - 2004
Senior Vice President, Drug Development Projects GlaxoSmithKline1998 - 2000
Vice President, Anti-infectives GlaxoSmithKline1995 - 1998
Gary Patou's Education
University College London, U. of London Doctor of Medicine (MD)
Investors who invest with Gary Patou
Founders who looked at Gary Patou's profile also looked at these Scouts & Angels